Back to Results
First PageMeta Content
Food and Drug Administration / Clinical research / Thiophenes / Healthcare quality / Medical terminology / Adverse Event Reporting System / Duloxetine / Pharmacovigilance / Rivaroxaban / Adverse effect / Adverse event / MedWatch


QuarterWatch Monitoring FDA MedWatch Reports Why Reports of Serious Adverse Drug Events Continue to Grow October 3, 2012 Data from 2012 Quarter 1
Add to Reading List

Document Date: 2012-10-03 12:53:27

Open Document

File Size: 406,52 KB

Share Result on Facebook
UPDATE